Bio Decontamination Market by Product (Equipment, Services, Consumables), Agent (Hydrogen Peroxide, Nitrogen, Peracetic Acid), Type (Room Decontamination, Chamber Decontamination), End User (Hospitals & Healthcare Facilities)- Global Industry Analysis, Share, Growth, Regional Outlook and Forecasts, 2022-2030

The global Bio Decontamination market size was estimated at USD 165 million in 2022 and is expected to surpass around USD 310 million by 2030 and poised to grow at a compound annual growth rate (CAGR) of 9.3% during the forecast period 2022 to 2030.

The rising pharmaceutical & biotechnology industry globally is anticipated to expand the demand for the bio-decontamination enterprise during the projection period. Moreover, the rising demand for hospital beds & ICUs and the increase in surgical procedures are also helping to propel market growth. However, the presence of manual decontamination methods, budgetary constraints in healthcare facilities, and the extensive lifecycle of bio-decontamination equipment are restraining the market growth. Furthermore, the increasing influx of advanced gassing systems, increasing demand for chamber decontamination, and developing equipment with less manual intervention are opportunities for market growth.

Report Scope of the Bio Decontamination Market

COVID-19 Impact

Factors such as the increasing demand for hospital beds and ICUs, the proliferation of isolation facilities, and the increasing awareness among consumers on bio decontamination products & services for medical devices and healthcare facilities have boosted the demand for bio decontamination products and services.

Further, in 2021, bio decontamination services were used by hospitals to convert COVID-19 wards to normal wards. For instance, Bioquell’s rapid bio decontamination service (RBDS) aided in returning the emergency COVID-19 ward to general use.

Also, COVID-19 has also impacted companies’ revenue in 2020 operating in the bio decontamination market. For instance, sales of Bioquell Global Healthcare & Life Sciences increased by 22% in 2020 due to strong demand for bio decontamination products. However, the segmental revenue declined by 4% in 2021 due to the decreased severity of COVID-19.

Bio Decontamination Market Dynamics

DRIVER: Growth in pharmaceutical & biotechnology industries

Bio decontamination equipment, services, consumables, and accessories are widely used in pharmaceutical companies, especially in parenteral (injectable) manufacturing. According to the European Federation of Pharmaceutical Industries & Associations (EFPIA), the global pharmaceuticals were USD 1,077,856 in 2020. Furthermore, according to the Pharmaceutical Executive, the top 15 pharmaceutical companies invested USD 133 billion in 2021 in R&D expenditure. With the rising R&D expenditure and the increasing focus on the development of new therapeutic and diagnostic products, the demand for state-of-the-art facilities equipped with modern machines & instruments and a properly decontaminated environment (for efficient & effective research and manufacturing) is expected to increase in the coming years. This is considered a positive indicator for the growth of the bio decontamination market during the forecast period.

OPPURTUNITY: Growing healthcare sector and increasing outsourcing in emerging economies

Emerging markets, such as India and China, are considered cost-saving hubs by developed countries. During the last decade, businesses in developed markets, such as the US and Europe, have outsourced their manufacturing and packaging operations to China, South Korea, Taiwan, and India to leverage the lower labor costs and less-stringent government regulations in these countries. As these countries are becoming major manufacturing hubs, there is a greater focus on quality parameters and the adoption of technologically advanced products to cater to customer requirements. Consequently, the adoption of bio decontamination products & services is growing across many industries in these countries

RESTRAINT: Presence of manual bio decontamination methods and budgetary constraints in healthcare facilities

Some of the common manual bio decontamination processes include spraying, manual cleaning with bleach or formaldehyde, and wiping with a suitable agent. Even though these methods have disadvantages, such as difficulties in the removal of residuals and difficulty in ensuring coverage over the entire area (particularly in rooms), they are still being used in various developing countries owing to their cost advantages. Also, hospitals and healthcare facilities in some developing and underdeveloped countries still have a low priority level for bio decontamination, as the healthcare infrastructure development in these countries focuses more on capital investments in medical devices and facility expansion. This is one of the major factors restraining the growth of the bio decontamination market in these countries.

In 2021,equipment segment accounted for the largest share of the bio decontamination market, by product and service

The global bio decontamination market is segmented into equipment, consumables, and service. equipment dominated the bio decontamination market in 2021. Factor contributing to the growth of this market segment is the preference of end users for automated bio decontamination over manual bio decontamination methods. Further, the newly launched equipments offer benefits such as portability, minimal footprint, and the need for less manual intervention which support the market growth.

In 2021, chamber decontamination accounted for the largest share in the market, by type

The bio decontamination market is segmented into room decontamination and chamber decontamination. The chamber decontamination segment accounted for the largest share of the bio decontamination market in 2021. Factors such as minimal cost and low power consumption are driving the growth of this segment. 

In 2021,pharmaceutical & medical device manufacturing companies segment accounted for the largest share in the market, by end user

The bio decontamination market is segmented into pharmaceutical & medical device manufacturing companies, life sciences & biotechnology research organizations, and hospitals & healthcare facilities. In 2021, pharmaceutical & medical device manufacturing companies accounted for the largest share of the bio decontamination market. This can be attributed to the high usage of bio decontamination products and services due to strict GMP manufacturing guideline in pharmaceutical & medical device manufacturing companies.

In 2021, North America accounted for the largest share of the bio decontamination market

The global bio decontamination market is segmented into four major regions namely, North America, Europe, the Asia Pacific, and Rest of the World. North America accounted for the largest share of the bio decontamination market in 2021. Factors such as the increasing incidence of HAIs, presence of key players, and the rising number of surgical procedures are contributing to the large share of this regional segment.

 Some of the prominent players in the Bio Decontamination Market include: Steris PLC (US), Ecolab (US), TOMI Environmental Solutions, Inc (US), JCE Biotechnology (France), Fedegari Autoclavi SpA (Italy), Zhejiang TAILIN Bioengineering Co., LTD (US), Howorth Air Technology Ltd. (UK), Solidfog Technologies (Belgium), ClorDiSys Solutions, Inc. (US), Amira SRL (Italy), Noxilizer, Inc. (US), Tecomak (UK), DIOP GmbH & Co. KG (Germany), AM Instruments srl (Italy), Allen & Company Environmental Services (US), Sychem Limited (UK), Controlled Contamination Services (US), Klenzaids (India), Curis Decontamination (US), IHSS Ltd (UK), METALL+PLASTIC GmbH (Germany), Bio Decontamination Ltd (UK), Syntegon Technology GmbH (Germany), The Ecosense Company (US), Reatorg (Russia),and CLEAMIX (Finland).

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2017 to 2030. For this study, Nova one advisor, Inc. has segmented the global Bio Decontamination market

By Product

• Equipment
• Services
• Consumables

By Agent Type

• Hydrogen Peroxide
• Chlorine Dioxide
• Peracetic Acid
• Nitrogen Dioxide

By Type

• Chamber Decontamination
• Room Decontamination

By End User

• Pharmaceutical & Medical Device Manufacturing Companies
• Life Sciences & Biotechnology Research Organizations
• Hospitals & Healthcare Facilities

By Geography

North America

• U.S.
• Canada

Europe

• Germany
• France
• United Kingdom
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Southeast Asia
• Rest of Asia Pacific

Latin America

• Brazil
• Rest of Latin America

Middle East & Africa (MEA)

• GCC
• North Africa
• South Africa
• Rest of Middle East & Africa

Key Points Covered in Bio Decontamination Market Study:

• Growth of Bio Decontamination in 2022
• Market Estimates and Forecasts (2017-2030)
•  Brand Share and Market Share Analysis
•  Key Drivers and Restraints Shaping Market Growth
•  Segment-wise, Country-wise, and Region-wise Analysis
•  Competition Mapping and Benchmarking
•  Recommendation on Key Winning Strategies
•  COVID-19 Impact on Demand for Bio Decontamination and How to Navigate
•  Key Product Innovations and Regulatory Climate
•  Bio Decontamination Consumption Analysis
•  Bio Decontamination Production Analysis
•  Bio Decontamination and Management